Lateral parietal contributions to memory impairment in posterior cortical atrophy by Ahmed, Samrah et al.
Accepted Manuscript
Lateral parietal contributions to memory impairment in posterior
cortical atrophy
Samrah Ahmed, Clare Loane, Sara Bartels, Giovanna Zamboni,
Clare Mackay, Ian Baker, Masud Husain, Sian Thompson,
Michael Hornberger, Christopher Butler
PII: S2213-1582(18)30217-1
DOI: doi:10.1016/j.nicl.2018.07.005
Reference: YNICL 1469
To appear in: NeuroImage: Clinical
Received date: 1 April 2018
Revised date: 4 June 2018
Accepted date: 3 July 2018
Please cite this article as: Samrah Ahmed, Clare Loane, Sara Bartels, Giovanna Zamboni,
Clare Mackay, Ian Baker, Masud Husain, Sian Thompson, Michael Hornberger,
Christopher Butler , Lateral parietal contributions to memory impairment in posterior
cortical atrophy. Ynicl (2018), doi:10.1016/j.nicl.2018.07.005
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PTE
D M
AN
US
CR
IPT
 
Lateral parietal contributions to memory impairment in posterior cortical atrophy 
 
Samrah Ahmeda, Clare Loaneb, Sara Bartelsc, Giovanna Zambonia,i, Clare Mackayd, Ian Bakere, Masud Husaina,f, Sian Thompsong, Michael 
Hornbergerh, Christopher Butlera 
 
aNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford UK. 
b Institute of Cognitive Neuroscience, University College London, London UK. 
cDepartment of Psychiatry and Neuropsychology and Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht 
University, Maastricht, The Netherlands. 
d Department of Psychiatry, University of Oxford, Oxford, UK. 
eRussell Cairns Unit, Oxford Radcliffe Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford UK. 
fDepartment of Experimental Psychology, University of Oxford, John Radcliffe Hospital, Oxford UK. 
gDepartment of Clinical Neurology, Oxford Radcliffe Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford UK. 
hNorwich Medical School, University of East Anglia, Norwich, UK 
iCenter for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Italy 
 
Correspondence to: Dr Samrah Ahmed, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, 
Oxford, OX3 9DU, Oxford, UK.  
Email: Samrah.ahmed@ndcn.ox.ac.uk  
 
Word count: 3499 
ACCEPTED MANUSCRIPT
AC
CE
PTE
D M
AN
US
CR
IPT
 
 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PTE
D M
AN
US
CR
IPT
ABSTRACT 
 
Objective: Posterior cortical atrophy (PCA) is a neurodegenerative syndrome characterised by progressive impairment in visuospatial and 
perceptual function. Recent findings show that memory functioning can also be compromised early in the course of disease. In this study, we 
investigated the neural basis of memory impairment in PCA, and hypothesised that correlations would be observed with parietal cortex rather 
than classic medial temporal memory structures. 
Methods: Eighteen PCA patients, 15 typical Alzheimer’s disease (tAD) patients and 21 healthy controls underwent memory testing with the Rey 
Auditory Verbal Learning Test (RAVLT) word list and MRI. Voxel-based morphometry (VBM) was used to identify regions in the parietal and 
medial temporal lobes that correlated with memory performance. 
Results: Compared with controls, PCA patients were impaired at learning, immediate and delayed recall and recognition of the RAVLT. 
Learning rate and immediate recall was significantly better in PCA compared to tAD, whereas there was no difference in delayed recall. 
Recognition memory also was not statistically different between patient groups, but PCA patients made significantly more false positive errors 
than tAD patients. VBM analysis in the PCA patients revealed a significant correlation between total learning and grey matter density in the 
right supramarginal gyrus, right angular gyrus and left postcentral gyrus. The left post central gyrus also significantly correlated with immediate 
and delayed recall and with recognition memory. No correlations were detected in the medial temporal lobe.  
Conclusions: The findings provide novel evidence that early verbal memory impairment is frequently observed in PCA, and is associated with 
damage to lateral parietal structures. The results have implications for the diagnosis and management of PCA. 
 
Keywords: posterior cortical atrophy; episodic memory; attention; Alzheimer’s disease. 
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1. INTRODUCTION 
 
Posterior cortical atrophy (PCA) is characterised by progressive impairment of visuospatial and visuoperceptual function that is not attributable 
to ocular disease (1, 2). Impaired object and space perception is prominent, often accompanied by other features of posterior cortical 
dysfunction. The most common underlying cause is Alzheimer’s pathology (3), although in a minority of cases alternative aetiologies, including 
corticobasal degeneration, dementia with Lewy bodies and prion disease, are implicated (4). 
 
Much research on PCA has concentrated on defining the visuospatial deficits (5). Diagnostic criteria emphasise that episodic memory is 
relatively spared in the early stages (1, 6). However, there is accumulating evidence of memory dysfunction in PCA(1, 7), and our work has 
shown that encoding and retrieval of new verbal information is significantly impaired in PCA patients compared to controls at initial 
presentation (8). Recently published consensus criteria also report that some PCA patients commonly report prominent memory disturbances at 
clinical presentation (4). Since memory impairment could be amongst the presenting features in PCA, there is a need for better understanding of 
the neurocognitive mechanisms underlying this impairment, mechanisms which have to date remained entirely unexplored. Compared with tAD, 
voxel-based morphometry (VBM) studies in PCA show relatively minimal involvement of classically implicated memory circuitry i.e. the 
medial temporal lobes (MTL) (9-11). Instead, PCA patients show a characteristic pattern of atrophy in parieto-occipital and temporo-occipital 
cortices compared with controls, with significant grey matter reductions predominantly in the right superior parietal lobe (10). Brain perfusion 
studies show bilateral and symmetrical hypoperfusion of the posterior cortex, with the most marked decrease found in the inferior parietal cortex 
(9).  
 
Memory is not a cognitive function typically credited to the lateral parietal regions. Classic discourses describing the function of the parietal lobe 
make little mention of memory processes (e.g., (12, 13)). Recent investigation, however, suggests that the lateral parietal cortex may play an 
integrative role in episodic memory that has been largely underappreciated. Episodic memory tasks consistently show greater lateral parietal 
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activation for encoding and retrieval of items, although more commonly for the latter process (14-16), and lesion studies of patients with focal 
parietal damage provide further supporting evidence (17, 18). Accordingly, given the relative sparing of the MTL in PCA, we hypothesize that 
memory impairment may be subserved by regions of the parietal lobe, and in particular, regions of the lateral parietal lobe that appear to be most 
severely compromised. This is in direct contrast to neural correlates of word list learning in AD. Using the Rey auditory verbal learning task 
(RAVLT), a widely used verbal episodic list learning task to quantify memory impairment in AD and preclinical AD, studies have shown 
consistent atrophy of medial temporal (19, 20) and medial parietal regions (21) across imaging modalities.  
 
The aim of this study was to characterise the behavioural and neuroanatomical profile of memory impairment in PCA. Speciﬁcally, we predicted 
that PCA patients would not differ from AD patient controls in free recall measures of new learning but that PCA patients would beneﬁt more 
from assessment of memory using recognition memory test formats, showing normal performance, given relative sparing of the MTL. 
Anatomically, we hypothesised that impairment on word list learning would correlate with sites of early and typical dysfunction in the lateral 
parietal regions in PCA, rather than classic memory structures of the TL. 
 
2. MATERIAL AND METHODS 
 
2.1.Participants 
 
18 PCA patients were recruited through the Oxford Cognitive Disorders Clinic, Oxford, UK. Diagnosis was established by a senior behavioural 
neurologist (CRB, ST or MH) and neuropsychologists (IB and SA). All patients fulfilled consensus criteria for PCA (2, 4), based upon clinical 
assessment, brain imaging and detailed neuropsychological assessment. Clinical magnetic resonance imaging (MRI) confirmed focal atrophy in 
the occipital and parietal lobes.  
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Three controls groups were used for comparison with the PCA patients. The first group (HC1) consisted of 21 healthy controls, and was used to 
analyse neuropsychological test performance in the PCA patients. These participants had no objective cognitive impairment (scored >88 on the 
Addenbrooke’s Cognitive Examination-Revised (22)), and no prior history of psychiatric illness, significant head injury, or cerebrovascular 
disease, and were not prescribed any medication known to affect cognition. 
 
The second group (tAD patient controls) consisted of 15 tAD patients, recruited from the dementia research clinic in Norwich, UK, as a disease 
control group for neuropsychological data analysis. tAD controls fulfilled consensus criteria for Alzheimer’s disease (23, 24), based upon 
clinical assessment, detailed neuropsychological assessment, and structural brain imaging. tAD patients showed marked impairment in episodic 
memory, with relatively preserved behaviour and personality, and characteristic bilateral medial temporal, with other more general atrophy.  
 
PCA patients, HC1 and tAD control groups were matched for age, years of education and gender distribution (Table 1). PCA and tAD controls 
were matched for symptom duration, i.e. time since the ﬁrst symptom was noticed. PCA patients did not demonstrate evidence of depressed 
mood or elevated stress levels, but did show significantly raised anxiety levels compared to controls. However, the group average (3.4) was still 
well within the normal range (0-7) on the Depression, Anxiety Stress Scale (DASS).  
 
A third control group (HC2) consisted of a further 32 healthy participants, and was used solely for analysis of the PCA neuroimaging data. These 
controls were recruited from the Oxford Project to Investigate Memory and Ageing and the Memory and Amnesia Project, University of Oxford, 
UK (cohorts described fully in (25, 26)). PCA patients and HC2 controls were matched for age (HC2: mean = 69.7 years, SD = 7.4; PCA: mean 
= 63.8 years, SD = 6.9; p >.05), education (HC2: mean = 14.5 years, SD = 3.5; PCA: mean = 13.7 years, SD = 1.9; p >.05), and gender 
distribution (HC2: 19 males, 13 females; PCA: 6 males, 7 females). HC1 and HC2 were also matched on age, education and gender (p>.05). 
 
-Table 1 here- 
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The study was approved by the National Research Ethics Service South Central - Hampshire B and Oxford C. All participants provided written 
informed consent in accordance with the Declaration of Helsinki.  
 
2.2 Background neuropsychological tests 
 
Standardised neuropsychological tests were administered to evaluate patient and control participant function in four domains:  
(i) Global cognition: Addenbrooke’s Cognitive Examination-III (27). 
(ii) Visuospatial function: Dot counting, position discrimination and cube analysis from the Visual Object and Space Perception (VOSP; 
(28) and the Rey-Osterrieth Complex figure (29). 
(iii) Visual imagery: Spatial Relations Test (adapted from (30, 31)), Letter Shape Test (32) and Tail Judgement Test (33). 
(iv)  Language: Oral Pyramids and Palm Trees (PPT; (34)), category fluency (35) and FAS letter fluency (36). 
 
2.3 Memory assessment 
 
2.3.1 Subjective memory questionnaires.  
PCA patients’ perspectives of their memory function were assessed using the Everyday Memory Questionnaire (EMQ; (37)) and carer 
perspectives were assessed using the Cambridge Behavioural Inventory-Revised (CBI-R; (38)). Both patients and carers were instructed to 
answer questions with regards to memory and thinking and not poor visual functioning. For example, on the EMQ the last question asks how 
frequently the individual fails to recognise a close friend or relative – the results (Table 2) show that the majority of patients (93%) do not 
experience this problem in terms of memory loss, whereas if answered in terms of visual and perceptual symptoms in PCA, a higher proportion 
of patients would be expected to endorse this symptom. In both questionnaires, Likert scales were collapsed to provide a rating for symptoms 
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experienced at three frequencies: Never, Frequent and Daily.  Specifically, the CBI-R scales was collapsed as follows: “Never” = Never 
category; “a few times per month” and “a few times per week” = Frequent category; “daily” and “constantly” = Daily category. The EMQ scales 
was collapsed as follows: “not at all” = Never category; “about once in the last 3 months”, “about once a month” and “about once a week” = 
Frequent category; “about once a day” and “more than once a day” = Daily category. 
 
2.3.2 RAVLT.  
The RAVLT (39) was used to measure objective memory performance. This well-validated instrument has been extensively employed to 
evaluate verbal episodic memory performance in various dementia syndromes (e.g. AD: (19-21); FTD: (40); PCA: (7)). A list of 15 unrelated 
words is read out to the participant five times, each time followed by free recall, in order to allow encoding of the word list. This is followed by 
an interference list of 15 new words. The original word list is then recalled immediately and at a delayed interval of 30 minutes. Recognition 
memory is assessed by presenting the participants with 50 words, consisting of 15 target words (i.e. the original word list) and 35 new words. If 
participants recognise a learned word, they respond “yes” (correct hit) and “no” to reject a new word. If participants incorrectly respond “yes” to 
a new word, it is scored as a false positive. A recognition memory index was calculated (hits - false positives) (41, 42) to describe recognition 
ability taking into account response bias. Values closer to the maximum 15 denote better recognition memory. 
 
2.4 Structural neuroimaging  
 
Image acquisition was conducted on a Siemens 3T Trio system using a 32-channel head coil at the University of Oxford Centre for Clinical 
Magnetic Resonance Research. High resolution, 3D T1-weighted images were acquired using a Magnetization Prepared Rapid Gradient Echo 
(MPRAGE) sequence (echo time = 4.7ms, repetition time = 2040ms, 8° flip angle, field of view = 192mm, voxel size = 1 x 1 x 1mm). Scans 
from 5 PCA patients were removed due to artifacts as a result of patient motion in the scanner. Structural data were analysed with an optimised 
protocol of the FSL-Voxel Based Morphometry (VBM) processing stream (see (43)). In brief, images were brain extracted using the brain 
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extraction tool (BET) (44) prior to tissue segmentation using the FMRIB Automatic Segmentation Tool (FAST).  Images were non-linearly 
registered to standard space and an average study-specific template was created. All images were then non-linearly aligned to the study-specific 
template and modulated for correction of local field expansion or contraction by dividing the Jacobian of the warp field. Modulated images were 
then smoothed with an isotropic kernel with a sigma of 3mm. Finally, voxel-wise statistics were employed using a general linear model with 
non-parametric permutation testing (45) and 5000 permutations per contrast.  
 
2.4.1 Whole brain VBM analysis.  
To investigate differences in cortical grey-matter between PCA patients and HC2, regression models were applied with separate directional 
contrasts (i.e. t-tests). Results were defined as significant at p < 0.001 corrected for multiple comparisons using the Threshold-Free Cluster 
Enhancement (TFCE) approach (46) carried out in Randomise with 5000 permutations per contrast. 
 
2.4.2 Region of interest analyses.  
Analysis of the anatomical correlates of RAVLT metrics in PCA patients was restricted to the parietal region, based on the hypothesis that 
atrophy in this region constitutes the characteristic cortical signature of PCA and is therefore most likely to underpin memory deficits in PCA. A 
control region mask of the MTL was used to determine the specificity of parietal effects, since this is the region most commonly associated with 
memory dysfunction in other forms of dementia. Binary masks of the bilateral parietal lobes (including the supramarginal gyrus, precuneus 
cortex, angular gyrus, postcentral gyrus and superior parietal lobule) and bilateral MTL were taken from the Harvard-Oxford cortical structural 
atlas. Correlational analyses were conducted between grey matter density within these masks and performance on total learning across RAVLT 
trials, immediate recall, delayed recall, correct recognition and recognition sensitivity index, with correction for multiple comparisons using the 
TFCE approach in Randomise with 5000 permutations per contrast and significance defined as p < 0.05. Age and gender were included as 
covariates in all analyses.  
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2.5 Statistical analyses 
 
Demographic, clinical, and cognitive characteristics were explored using one-way analysis of variance with Sidak post hoc tests or independent 
samples t-tests, and Chi-squared tests for gender differences. RAVLT metrics were explored using Kruskal-Wallis nonparametric tests, with 
Mann-Whitney tests for pairwise comparisons. Spearman’s rank correlation coefficient was used to explore relationships between RAVLT 
metrics and clinical variables. Two-tailed tests were conducted with alpha level set at 0.05, with Bonferroni correction applied for multiple 
comparisons.  
 
3. RESULTS 
 
3.1 Background neuropsychological assessment 
 
PCA patients were impaired on all visuospatial and visual imagery tests compared to HC1, in keeping with the clinical phenotype of this 
syndrome, with some decline in language also (Table 1). Both PCA and tAD patients were impaired on the ACE-III compared to HC1, but there 
was no significant difference between patient groups. 
 
3.2 Memory assessment 
 
3.2.1 Subjective memory questionnaires.  
The most common observations endorsed by carers (those observed by >75% of carers as occurring frequently or daily) referred to symptoms 
related to memory retrieval and spatial memory. The most common subjective experiences of memory loss (those endorsed by >75% of PCA 
patients) also pertained to memory retrieval, as well as task monitoring and memory for everyday activities (Table 2). 
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-Insert Table 2 here- 
 
3.2.2 RAVLT.  
Both PCA and tAD patients learnt significantly fewer words across trials compared to HC1, and there was no significant difference between 
patient groups (Table 1). Both patient groups were impaired compared to HC1 on immediate recall, but PCA patients recalled significantly more 
than tAD patients. To further explore encoding, rate of learning was computed (calculated as Trial 5 recall - Trial 1 recall; (47)). Although both 
PCA and tAD groups showed significantly reduced rate of learning compared to HC1 (PCA: p=.022; tAD: p=.040), PCA patients showed 
significantly more rapid learning than tAD patients (p=.040) (Figure 1). 
 
-Insert Figure 1 here- 
 
At retrieval, both patient groups were impaired compared to HC1 on delayed recall, and there was no difference between patient groups. 
Examining recognition, PCA patients were comparable to HC1 in correct identification of previously learned words (recognition hits), while the 
tAD group was impaired compared to HC1 and PCA patients. Conversely, PCA patients produced significantly more false positives compared to 
HC1, while the tAD group showed no difference compared to HC1, although there was no significant difference between the patient groups. The 
recognition memory index revealed that, once the number of false positives was accounted for, both PCA and tAD groups were impaired 
compared to HC1, and the performance of both patient groups was comparable.  
 
3.3 Other clinical considerations 
 
Mood, symptom duration and impaired visual imagery were explored for their potential influence on poor memory performance in PCA.  
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3.3.1 Mood.  
There were no significant correlations between DASS stress, anxiety or depression measures with any of the RAVLT metrics (all p values >.05).  
 
3.3.2 Symptom duration.  
To explore whether the memory profile in PCA was being driven by patients with a longer symptom duration who may have accumulated more 
widespread cognitive symptoms, PCA patients were divided into two subgroups based on median length of symptom duration (median =3.3 
years), replicating the method used by Kas et al. (9): (i) a short symptom duration group defined as having less than or equal to three years 
symptom duration (n=9); and (ii) a long symptom duration defined as having greater than three years symptom duration (n=9). There were no 
significant differences between these groups on any of the RAVLT metrics (all p values >.05). Supplementary analysis using symptom duration 
as a continuous variable revealed no significant correlations with the RAVLT. 
3.3.3 Visual imagery. 
Poor visual imagery in PCA patients may impact the encoding process, based on evidence that visual strategies and mental imagery are 
commonly used to encode words presented in the auditory modality (48). There were no significant correlations between visual imagery tasks 
and RAVLT metrics. 
 
3.4 Structural neuroimaging 
 
3.4.1 Whole brain analyses.  
VBM analysis revealed significant decreases in grey matter density in PCA patients relative to HC2 (Figure 2). PCA patients showed 
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characteristic pronounced changes, largely bilateral, in the lateral occipital cortex, and in lateral and medial parietal regions, including the 
parietal lobule, angular gyrus, the supramarginal gyrus, precuneus and posterior cingulate. Medial temporal regions were largely spared except 
for grey matter density reduction in bilateral posterior parahippocampal gyrus and posterior hippocampus (Table 3).  
 
- Figure 2 here – 
- Table 3 here – 
 
3.4.2 Region of interest analyses.  
Analyses within the parietal lobe mask revealed a significant correlation between total learning across trials and grey matter density in the right 
supramarginal gyrus, right angular gyrus and left postcentral gyrus. The left post central gyrus also significantly correlated with immediate and 
delayed recall, correct recognition (Figure 3). No correlations were detected between grey matter density within the parietal mask and the 
recognition memory index. No correlations with RAVLT metrics were detected within the MTL mask.    
   
- Figure 3 here - 
    
4. DISCUSSION 
 
This study provides novel evidence that, contra to traditional understanding, PCA is associated with early verbal memory impairment. Moreover, 
the degree of memory impairment correlates with atrophy in the lateral parietal cortex rather than regions typically associated with memory 
impairment, such as the MTL in tAD.  
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Compared with healthy controls, PCA patients were impaired at learning, immediate recall and delayed recall of the RAVLT word list. 
Nevertheless, PCA patients performed better than tAD patients on measures of learning rate and immediate recall, although their delayed recall 
was not significantly different. This overall impairment of verbal recall in PCA is in line with the subjective complaints of patients, and with our 
previous, retrospective study (8). Importantly, the results could not be explained as a function of disease progression or mood disorder. However, 
whilst we expected to see a relative sparing of recognition memory in PCA, this was not observed. Although PCA patients scored as many ‘hits’ 
as healthy controls, this was due to a response bias indicated by their greater number of ‘false positive’ responses. The reason for this response 
bias is unclear. A recent study suggests disinhibition may play a role, i.e. patients are unable to constrain endorsement of recognition items (49), 
although on the CBI-R, disinhibition did not emerge as a prevalent feature in PCA. An alternative possibility is that PCA patients have reduced 
confidence in their memory, akin to that observed in patients with parietal lesions (18), leading to a liberal response bias. Further studies are 
needed to explain this observation. 
 
Investigating the neural substrate of the verbal memory deficit in PCA, we found that atrophy in lateral parietal regions correlated with both 
encoding and retrieval. Specifically, grey matter density in the right supramarginal gyrus, right angular gyrus and left postcentral gyrus 
correlated with total learning across trials, and the left postcentral gyrus with immediate recall, delayed recall and correct recognition. No 
correlations were identified between memory performance and MTL atrophy. This is strikingly different from extensive previous research in 
tAD, where learning and retrieval impairments have consistently been attributed to pathology in the hippocampus and surrounding cortex (e.g. 
(19-21)).  
 
Two possible explanations for the observed neuroanatomical profile may be considered. First, the supramarginal gyrus has been associated with 
the phonological loop (50), which supports auditory-verbal working memory (51). Accordingly, supramarginal gyrus atrophy in PCA may 
disrupt working memory processes essential in a verbal memory task. However, such processes are likely to be most critical to successful 
encoding of verbal information and therefore to learning of the initial trials on the RAVLT. For example, in tAD patients, Wolk et al. (20) found 
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that reduced cortical thickness in the supramarginal gyrus correlated with learning on the initial trial of the RAVLT, while MTL structures 
correlated with total learning and delayed recall. In contrast, our results demonstrate that the supramarginal gyrus was associated with total 
learning and delayed recall in PCA patients, suggesting that impaired auditory-working memory is unlikely to be the primary deficit 
underpinning the memory impairment.  
 
A second and more compelling possibility is that the lateral parietal correlates of memory in PCA reflect the hitherto under-recognised 
significance of these regions in episodic memory. Classic theories of memory would hypothesise that, because MTL involvement is not an early 
feature of PCA, patients should have relatively intact long-term declarative memory. However, an increasing number of fMRI (eg. (52) and 
lesion (e.g. (14) studies have demonstrated a role for bilateral parietal cortex in both the encoding and retrieval of memories. The parietal cortex 
is also firmly linked with attentional processing and a rich body of neuropsychological, neurophysiological and neuroimaging literature shows 
anatomical co-localization of memory and attention processes in the lateral parietal cortex (see (15, 16) for reviews), functionally dissociated 
along a dorsal (superior parietal lobe) and ventral (inferior parietal lobe, specifically the supramarginal gyrus) axis. Dorsal parietal mechanisms 
are proposed to direct attention to information that is relevant to the goal (top-down attention), enhancing cortical representation of the 
information being attended to and thus increasing the likelihood of later remembering. Ventral parietal mechanisms, by contrast, are proposed to 
be active when attention is captured by salient information (bottom-up attention), weakening later recall when attention is captured by 
information irrelevant to the task (53, 54). The post central gyrus is frequently reported as part of the functional anatomy of attention and more 
specifically as part of the frontoparietal cortical network for directing attention (55). This may explain the correlation of the postcentral gyrus 
with several metrics from the RAVLT, and suggests a critical role for attention in episodic memory. Accordingly, we propose that memory 
impairment in PCA may be driven by the primary pathology in the parietal cortex, specifically affecting the attentional networks underlying 
memory processes.  
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Our results have important clinical implications. Memory is impaired early in the course of PCA, alongside the initial, defining visuo-perceptual 
impairments. As such memory assessments may aid accurate and early diagnosis of PCA, potentially within an optimal therapeutic window. 
Moreover, memory assessment may have particular utility in disease monitoring, since PCA patients typically perform at, or close to, floor on 
visual tasks even in the early stages of disease. If the attentional basis of memory impairment in PCA is borne out by future studies, everyday 
memory performance may be enhanced by implementing organisational or categorical cues at the time of encoding and by minimising 
attentional demands, directing attention and supporting retrieval (e.g. (56)). Finally, the efficacy of pharmaceutical intervention for memory 
impairment in PCA should be explored. Research in tAD shows that deficits in shifting attention have been linked to reduced cholinergic 
innervation associated with hypometabolism of the posterior parietal cortex (57), and that administration of acetylcholinesterase inhibitors 
improves attention (58).  
 
Our study has some limitations, which could be addressed by future research in order to investigate further the nature of memory impairment in 
PCA. First, visual imagery tests were not administered to the tAD group, and thus we were not able to explore differences between patient 
groups in visual imagery performance and its potential impact upon memory. Additional tests of attention and working memory could also be 
employed to understand more completely the contribution of these systems to memory impairment in PCA. Second, whilst the RAVLT has been 
used extensively to explore memory impairment in dementia (19-21) components of memory (i.e. encoding, recall and recognition) could be 
more systematically studied using free and cued memory tests (e.g. (59)) that control encoding and retrieval of the material to be learnt. 
 
4.1 Conclusions 
 
In summary, the results of this study provide the first description of the neural correlates of memory impairment in PCA, and strongly suggest 
that the deficits are underpinned by damage within parietal rather than medial temporal lobe networks. Future work is warranted to explore the 
relationship between attention and memory in PCA. 
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Table 1. Demographic and clinical characteristics of control and patient groups. Standard deviation given in brackets. Total scores achievable on 
neuropsychological tests, where applicable, in brackets in right column. Values in bold indicate significant group differences.  
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 HC1 HC2 PCA tAD HC1 x PCA HC1 x tAD PCA x tAD HC1 x HC2 
Demographics          
N 21 45 18 15 - - -  
Age (yrs) 63.4 (6.1) 64.4 (7.2) 64.9 (6.8) 68.6 (9.7) .898 .126 .411 .577 
Education (yrs) 14.4 (2.1) 14.2 (3.0) 13.6 (2.0) 12.6 (6.5) .821 .413 .824 .751 
Gender (m:f) 9:12 25:20  
#’;lmn 9:9 
8:7 .656 .535 .849 .336 
Symptom duration (yrs) - /. M,./ 3.8 (1.9) 3.0 (0.8) - - .130  
DASS1 depression scale (normal range 0-9) 2.1 (2.5)  5.5 (9.3) - .119 - -  
DASS anxiety scale (normal range 0-7) 1.0 (2.1)  3.4 (3.1) - .019 - -  
DASS stress scale (normal range 0-14) 4.0 (4.5)  5.6 (5.0) - .318 - -  
Background neuropsychological profile         
ACE III Total (100) 96.0 (4.3)  55.4 (15.7) 66.9 (22.1) .000 .000 .092  
ACE III Attention (18) 17.1 (1.5)  10.9 (3.6) 12.2 (4.9) .000 .000 .621  
ACE III Memory (26) 24.7 (2.1)  14.9 (5.2) 12.6 (6.4) .000 .000 .405  
ACE III Fluency (14) 12.7 (1.5)  7.9 (4.2) 8.1 (3.6) .000 .000 .995  
ACE III Language (26) 25.7 (0.96)  18.4 (6.4) 21.7 (5.9) .000 .055 .153  
ACE III Visuospatial function (16) 15.7 (0.72)  3.8 (3.8) 12.3 (3.4) .000 .002 .000  
Visuospatial function         
VOSP dot counting1 (10) 10.0 (0)  3.9 (3.7) - .000 - -  
VOSP position discrimination1 (20) 19.6 (1.1)  13.5 (3.8) - .000 - -  
VOSP cube analysis1 (10) 9.5 (1.2)  1.8 (2.3) - .000 - -  
Rey-Osterrieth complex figure copy1 (18) 17.6 (0.74)  1.8 (3.1) - .000 - -  
Visual imagery         
Spatial relations: categorical (12) 11.5 (0.93)  8.4 (2.3) - .000 - -  
Spatial relations: metric (12) 11.0 (0.67)  7.9 (2.5) - .000 - -  
Spatial relations: total (24) 22.4 (1.2)  15.8 (4.0) - .000 - -  
Animal imagery (20) 18.0 (1.0)  15.4 (2.3) - .000 - -  
Letter imagery (20) 19.3 (0.85)  15.8 (3.4) - .000 - -  
Language          
Pyramids and Palm Trees1 (52) 51.6 (0.68)  46.6 (3.0) - .001 - -  
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Category fluency1 21.2 (3.8)  9.4 (6.6) - .000 - -  
FAS1 46.7 (12.9)  32.5 (18.4) - .008 - -  
RAVLT         
Total learning across 5 trials (75) 49.7 (9.0)  29.5 (11.7) 24.2 (13.5) .000 .000 .343  
Immediate recall (15) 10.3 (2.9)  5.1 (3.3) 2.9 (2.2) .000 .000 .040  
Delayed recall (15) 10.2 (3.2)  4.3 (4.0) 2.7 (2.4) .000 .000 .229  
Recognition hits (15) 13.9 (1.6)  13.1 (2.2) 10.1 (4.5) .349 .001 .030  
Recognition false positives (35) 2.0 (2.8)  9.5 (7.6) 4.4 (5.1) .001 .222 .077  
Recognition memory index (15) 11.8 (3.7)  3.6 (8.1) 5.7 (5.3) .001 .001 .464  
 
Abbreviations: ACE III Addenbrooke’s Cognitive Examination; DASS Depression anxiety stress scale; HC1 Healthy controls group 1 (controls for behavioural data); HC2 
Healthy control group 2 (controls for imaging data); PCA Posterior cortical atrophy; tAD typical Alzheimer’s disease; VOSP Visua l object and space perception; RAVLT 
Rey auditory verbal learning task. 
 
1Missing data: Data in PCA patients was missing for some tests due to the test being ended on the patients’ request: Reduced sample sizes were present for: Rey figure 
(n=9); VOSP cube analysis (n=10); VOSP dot counting (n=18); VOSP position discrimination (n=11); PPT (n=17); FAS (n=17); Category fluency (n=1 7); DASS (n=14). 
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 Frequency of complaint (%) 
Carer observation (N=16) 
(from the Cambridge Behavioural Inventory-Revised; Wedderburn et al. 2008) 
Never Frequent Daily No 
answer 
Poor day-to-day memory 37.5 19 37.5 6 
Asks the same questions over and over again 56 25 19 0 
Loses/misplaces things 6 44 44 6 
Forgets the names of familiar people 12.5 75 12.5 0 
Forgets the names of objects and things 6 62.5 25 6 
Poor concentration when reading/watching television 12.5 31 37.5 19 
Forgets what day it is 25 62.5 12.5 0 
Becomes confused/muddled in unusual surroundings 6 44 44 6 
PCA patients’ subjective complaints (N=14) 
(from the Everyday Memory Questionnaire; Sunderland et al. 1983, 1984) 
    
Forget where you put something 0 22 64 14 
Fail to recognise places that you are told you have been to often before 64 22 7 7 
Fails to remember a change in your daily routine 36 57 0 7 
Have to go back to check whether you had done something you meant to do 7 43 36 14 
Forget that you were told something yesterday/few days ago 14 64 22 0 
Let yourself ramble on to speak about unimportant/irrelevant things 57 43 0 0 
Have difficulty picking up a new skill 14 43 36 7 
Find that a word is “on the tip of your tongue” 0 36 64 0 
Forget important details of what you did/forget what happened to you the day before 50 43 0 7 
Forget important details about yourself 79 21 0 0 
When talking to someone, forget what you had just said 29 50 14 7 
When reading a newspaper/magazine, being unable to follow the thread of the 
story/lose track of what it was about 
36 29 21 14 
Forget to tell somebody something important 71 29 0 0 
Get the details of what somebody has told you mixed up/confused 14 72 14 0 
Forget people’s names 14 36 50 0 
Get lost/turn in the wrong direction on a journey/walk/in a building you have only 
been to once/twice before 
14 50 14 22 
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Repeat to someone what you have told them/ask the same question twice 64 29 7 0 
Fail to recognise a close relative 93 0 0 7 
 
 
Table 2. Frequency of memory complaints observed by carers or expressed by PCA patients (at average symptom duration of 3.8 years). Symptoms 
highlighted in bold denote those that were endorsed by more than 75% of the patient or carer group as occurring frequently or daily. 
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Contrast Regions Cluster size Coordinates T value 
PCA < HC2  Left: 
paracingulate cortex, paracingulate gyrus 
Right: 
middle frontal gyrus 
Bilateral: 
superior parietal lobule, precentral gyrus, supramarginal gyrus, postcentral gyrus, 
posterior cingulate, angular gyrus, parietal operculum cortex, Heshl’s gyrus, insular 
cortex, thalamus, superior temporal gyrus, middle temporal gyrus, inferior temporal 
gyrus, posterior parahippocampal gyrus, posterior hippocampus, putamen, caudate, 
precuneus, lingual gyrus, occipital fusiform gyrus, lateral occipital cortex, temporal 
fusiform gyrus, brain stem 
98,166 56, -30, -4 7.86 
Abbreviations: PCA Posterior cortical atrophy; HC2 Healthy controls group 2 (controls for imaging analysis)  
 
Table 3. Results from voxel-based morphometry analyses. All clusters were significant at p < 0.001 family-wise error corrected using threshold-free cluster 
enhancement method.  
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FIGURE LEGENDS 
 
Figure 1. Rate of learning (Trial 5 – Trial 1) across groups. Error bars represent standard error of the mean. (* p<.05) 
 
Figure 2. Voxel based morphometry maps displaying reduced grey matter density in HC2 > PCA. The comparison was significant at p < 0.001 
FWE corrected using TFCE method. Colour bars indicates T-values of statistically significant voxels 
 
Figure 3. Voxel based morphometry maps displaying correlation between reduced grey matter density in A = right supramarginal gyrus, right 
angular gyrus and left postcentral gyrus with total learning across trials; B = left postcentral gyrus with immediate recall; C = left postcentral 
gyrus with delayed recall and D = left postcentral gyrus with correct recognition in the PCA patients. Findings were significant at p < 0.01 FWE 
corrected using TFCE method (p values by colour bar).  
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Highlights:  
 
 PCA patients were impaired in learning, recall and recognition memory. 
 Deficits were evident in the early stages of disease. 
 Memory impairment was associated with damage to lateral parietal structures.  
 No correlations were detected in the medial temporal lobe. 
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